From Extraction to Cryobanking: Which Critical Process Parameters Genuinely Improve DPSC Production?
Authors:
- Tomasz GedrangeTomasz Gedrange
- Benita WiatrakBenita Wiatrak
- Tomasz GęBarowskiTomasz GęBarowski
- Ewa BargEwa Barg
- Łucja Cwynar-ZającŁucja Cwynar-Zając
- Katarzyna GęBczakKatarzyna GęBczak
- Helena MoreiraHelena Moreira
- Aneta Cieśla-NiechwiadowiczAneta Cieśla-Niechwiadowicz
- Jakub HadzikJakub Hadzik
- Amelie LuppAmelie Lupp
- Sophie GedrangeSophie Gedrange
- Marzena DominiakMarzena Dominiak
Open Access
- 7 March 2026
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 429
Abstract
Background: Advanced therapy medicinal products (ATMPs) require strict control of critical process parameters (CPPs) to ensure manufacturing efficiency. The relative impact of donor systemic factors, such as vitamin D status, versus technical process parameters on dental pulp-derived stem cell (DPSC) production remains unclear. Methods: In this prospective observational study, 250 adults undergoing extraction of impacted mandibular third molars were included. Dental pulp was processed under a standardized SOP using different preparation methods and enzyme conditions. Primary endpoints were serum 25(OH)D concentration and cell yield; secondary endpoints included number of passages and cryovials. Results: Mean 25(OH)D concentration was 30.1 ± 14.5 ng/mL and was higher in supplemented individuals (38.2 ± 14.0 vs. 25.6 ± 12.7 ng/mL; p < 0.0001) but was not associated with cell yield (ρ = 0.14, p = 0.168) or passages (ρ = 0.07, p = 0.406). In contrast, process parameters showed strong effects: scissor preparation resulted in a substantially higher yield than mechanical methods (median 5.00 vs. 1.00 million cells; p = 3.6 × 10−13), and type II collagenase was independently associated with a higher yield (+2.04 million cells; p = 0.026). The number of passages was the strongest predictor of yield (β = 2.28 million per passage; p < 10−26). Post-thaw viability remained high (mean 90.1% and range 81–98%). Conclusions: Manufacturing efficiency of DPSCs is primarily determined by critical process parameters, particularly preparation method, enzyme selection, and passage control, whereas donor vitamin D status did not significantly influence outcomes under the studied SOP. These findings highlight process standardization as the key driver of reproducible ATMP manufacturing.Keywords
Funding Information
- European Union from the European Regional Development Fund
- National Center for Research and Development (POIR.04.01.01-00-0006/19-00)
This publication has 30 references indexed in Scilit:
- Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell TherapiesClinical Pharmacology & Therapeutics, 2024
- Alkaline phosphatase: Structure, expression and its function in bone mineralizationGene, 2020
- Physiology of Parathyroid HormoneEndocrinology and Metabolism Clinics of North America, 2018
- Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trialThe Lancet Diabetes & Endocrinology, 2017
- Developmental Vitamin D Availability Impacts Hematopoietic Stem Cell ProductionCell Reports, 2016
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 2015
- Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studiesEuropean Journal of Cancer, 2014
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Problems of supernumerary teeth, hyperdontia or dentes supernumerariiAnnals of Anatomy - Anatomischer Anzeiger, 2006
- Some heteroskedasticity-consistent covariance matrix estimators with improved finite sample propertiesJournal of Econometrics, 1985